|
|||||
|
|
An enterprise developing a synthetic antibody to treat breast cancer, spun-off from a University at Buffalo research lab, is taking part in a federal program to advance the treatments to clinical trials. . . . → Read More: Univ. Spinoff Qualifies for NIH Clinical Program  Comments are closed  New products  biomedical, biotechnology, cancer, clinical trials, entrepreneurs, licensing, life sciences, NIH, pharmaceuticals, university 
A clinical trial is recruiting participants to test a vaccine to protect against a variety of influenza strains, instead of today’s vaccines designed to prevent infections from specific strains expected in a given year. . . . → Read More: Trial Underway Testing Universal Flu Vaccine Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, health care, Israel, life sciences, NIH, pharmaceuticals, university 
An analysis of the impact of proposed cuts in funds for research and development on technologies to address global health needs shows the U.S. economy benefits directly from this spending, including support of many jobs in nearly all states. . . . → Read More: Global Health R&D Cuts Threaten U.S. Economy, Jobs One comment - (Comments are closed) Business conditions biomedical, economics, health care, life sciences, NIH, statistics A bioengineering group created a process for producing a cough suppressant in the lab, usually derived from opium poppies, but instead from genetically modified brewer’s yeast. . . . → Read More: Cough Suppressant Produced from Engineered Yeast Cells Comments are closed Intellectual property, New products biomedical, biotechnology, cancer, engineering, entrepreneurs, genomics, grant, licensing, life sciences, NIH, NSF, patent, pharmaceuticals, university Small doses of a drug for blood-related cancers are shown in lab mice to reverse social symptoms often found in children with autism spectrum disorder, a condition characterized by limited social activity. . . . → Read More: Cancer Drug Seen to Reverse Autism Spectrum Symptoms Comments are closed New products biomedical, cancer, entrepreneurs, grant, life sciences, NIH, pharmaceuticals, preclinical, university Clinical trials are underway in the U.S. as part of a larger international project testing synthetic antibodies designed to prevent infections from bacteria often found in hospitals and clinics. . . . → Read More: Trials Test Antibodies to Prevent Hospital Infections Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, clinical trials, Europe, grant, life sciences, NIH, pharmaceuticals, university The director of the National Institute on Drug Abuse says recent research in neuroscience and pharmacology reveals possible pathways out of the current epidemic of opioid addiction and overdose deaths. . . . → Read More: NIH Exec: Research Offers Opioid Crisis Solutions A start-up company spun-off from Washington University in St. Louis was awarded a grant to advance an augmented reality system that displays an interactive hologram of a patient’s heart, to simplify cardiac procedures. . . . → Read More: Cardiac Augmented-Reality Hologram System in Development Comments are closed Finance, New products biomedical, computer science, engineering, entrepreneurs, grant, heart disease, life sciences, mathematics, medical device, NIH, physical sciences, software, university A bioengineering lab is receiving a National Institutes of Health grant to advance development of more tolerable synthetic veins and arteries implanted in heart bypass patients. . . . → Read More: NIH Funding Immune-Friendly Synthetic Vascular Grafts Comments are closed Finance, New products biomedical, engineering, grant, heart disease, life sciences, medical device, NIH, physical sciences, preclinical, university A process is being developed to quickly discover antibodies in a person’s immune system that can also lead to new vaccines and drugs against viruses. . . . → Read More: Technique Developed for High-Speed Antibody Screening Comments are closed New products biomedical, chemistry, engineering, genomics, life sciences, NIH, patent, pharmaceuticals, physical sciences, university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
